eosine yellowish-(ys) has been researched along with Cancer of Pancreas in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, JW; Kim, H; Kim, SC; Kim, YT; Ku, JL; Lee, JH; Lee, SH; Lee, SK; Lowy, AM; Paik, WH; Ryu, JK; Seo, HY | 1 |
| Abdul Majid, AMS; Asif, M; Kaur, G; Oon, CE; Subramaniam, AV; Yehya, AHS | 1 |
| Adsay, V; Basturk, O; Besselink, MG; Brosens, L; Campbell, F; Chatterjee, D; Chou, A; de Boer, O; Doglioni, C; Esposito, I; Fariña, A; Feakins, R; Fuchs, TL; Fukushima, N; Gill, AJ; Hong, SM; Hruban, RH; Janssen, BV; Kaplan, J; Krasinkas, A; Luchini, C; Shi, C; Singhi, A; Thompson, E; van Dieren, S; van Roessel, S; Velthuysen, MF; Verbeke, C; Verheij, J; Wang, H | 1 |
| Bastian, MB; Buchholz, M; Helmprobst, F; Jedelská, J; König, AM; Mahnken, AH; Pagenstecher, A; Scheschenja, M; Tatura, M; Wessendorf, J | 1 |
| Abbasi, S; Bell, K; Bigras, G; Dinakaran, D; Haji Reza, P; Le, M; Mackey, JR; Sonier, B | 1 |
| Chen, H; Chen, J; Chen, Y; Hong, Z; Zhu, X; Zhuo, S | 1 |
| Chen, J; Chen, Y; Liao, C; Xu, Y; Zhu, X | 1 |
| Deshpande, V; Fernández-Del Castillo, C; Ferrone, CR; Ferrone, S; Ligorio, M; Lillemoe, KD; Mahadevan, KK; Sabbatino, F; Ting, DT; Vangel, M; Villani, V; Wargo, J; Warshaw, AL; Zhang, I | 1 |
| Chhieng, DC; Crowe, R; Eloubeidi, MA; Eltoum, IA; Jhala, D; Jhala, NC; Siegal, GP; St John, KD; Tamhane, A; Vickers, S; Wilcox, CM | 1 |
| alAnsari, AG; Gupta, RK | 1 |
| Albertson, DA; Cappellari, JO; Geisinger, KR; Kute, TE; Wolfman, NT | 1 |
| Daly, JM; Morgan, RG; Oates, PS; Tee, LB; Yeoh, GC | 1 |
12 other study(ies) available for eosine yellowish-(ys) and Cancer of Pancreas
| Article | Year |
|---|---|
Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Eosine Yellowish-(YS); Hematoxylin; Humans; Organoids; Pancreatic Neoplasms | 2022 |
Anti-tumour activity and toxicological studies of combination treatment of
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Eosine Yellowish-(YS); Gemcitabine; Heterografts; Humans; Ki-67 Antigen; Mice; Mice, Nude; Necrosis; Orthosiphon; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2022 |
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1).
Topics: Eosine Yellowish-(YS); Humans; Neoadjuvant Therapy; Observer Variation; Pancreatic Neoplasms; Reproducibility of Results | 2022 |
Feasibility of the chick chorioallantoic membrane model for preclinical studies on tumor radiofrequency ablation.
Topics: Animals; Chickens; Chorioallantoic Membrane; Eosine Yellowish-(YS); Feasibility Studies; Humans; Ki-67 Antigen; Pancreatic Neoplasms | 2023 |
All-optical Reflection-mode Microscopic Histology of Unstained Human Tissues.
Topics: Breast Neoplasms; Eosine Yellowish-(YS); Female; Gastrointestinal Neoplasms; Hematoxylin; Humans; Microscopy; Pancreatic Neoplasms; Tonsillar Neoplasms | 2019 |
Multiphoton microscopy as a diagnostic imaging modality for pancreatic neoplasms without hematoxylin and eosin stains.
Topics: Adult; Aged; Coloring Agents; Eosine Yellowish-(YS); Female; Hematoxylin; Histocytochemistry; Humans; Male; Microscopy, Fluorescence, Multiphoton; Middle Aged; Pancreas; Pancreatic Neoplasms | 2014 |
Two-photon excited fluorescence imaging of the pancreatic solid pseudopapillary tumor without hematoxylin and eosin stains.
Topics: Coloring Agents; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Microscopy, Fluorescence; Neoplasms, Glandular and Epithelial; Pancreatic Neoplasms | 2016 |
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Proliferation; Coloring Agents; Disease-Free Survival; Eosine Yellowish-(YS); Female; Hematoxylin; Histones; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphorylation; Proportional Hazards Models; ROC Curve; Survival Rate; Time Factors; Young Adult | 2016 |
Cytologic grade independently predicts survival of patients with pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Azure Stains; Eosine Yellowish-(YS); Female; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Proportional Hazards Models; Reproducibility of Results | 2005 |
Needle aspiration cytology in the diagnosis of mucinous cystadenocarcinoma of pancreas. A study of five cases with an emphasis on utility and differential diagnosis.
Topics: Adenocarcinoma; Aged; Alcian Blue; Biopsy, Needle; Carmine; Coloring Agents; Cystadenocarcinoma, Mucinous; Diagnosis, Differential; Eosine Yellowish-(YS); Hematoxylin; Humans; Male; Pancreas; Pancreatic Neoplasms; Staining and Labeling | 1994 |
Malignant papillary cystic tumor of the pancreas.
Topics: Abdominal Neoplasms; Adult; Biopsy, Needle; Carcinoma, Papillary; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Pancreatic Neoplasms; Staining and Labeling | 1990 |
Glutathione S-transferase (mu class) as an early marker of azaserine-induced foci in the rat pancreas.
Topics: Animals; Azaserine; Biomarkers, Tumor; Eosine Yellowish-(YS); Glutathione Transferase; Hematoxylin; Isoenzymes; Male; Pancreatic Neoplasms; Precancerous Conditions; Rats; Rats, Inbred Strains; Staining and Labeling | 1991 |